Evaluation of the performance of the quotient MosaiQ™ COVID-19 professional use microarray assay for the detection of antibodies to SARS CoV-2 in a clinical setting

Autor:	Javier Sánchez-Bonilla, Rebeca Saez, José Vicario, Luisa Barea-Garcia, Raquel Alenda-Asensi, Reginald Clayton, David Cooper Robson, Irene Lucea-Gallego, Janine Scott Robb
Rok vydání:	2020
Předmět:	medicine.medical_specialty education.field_of_study Microarray biology business.industry Population Infectious and parasitic diseases RC109-216 Article Serology Vaccination Pandemic Cohort biology.protein Medicine Antibody business Intensive care medicine education Health policy
Zdroj:	Journal of Clinical Virology Plus Journal of Clinical Virology Plus, Vol 1, Iss 1, Pp 100022-(2021)
ISSN:	2667-0380
Popis:	As the SARS-CoV-2 pandemic progresses and public and patient health providers seek advice and guidance to inform health policy, the value of serological testing in establishing infection rates and correlates of immune protection will become elucidated. The detection of antibody responses may enable post- diagnosis management, the identification of asymptomatically infected individuals, and assessment of pandemic spread on a population or cohort basis. Serological testing may also be useful in the formulation of lock-down or exit strategies, safe return to work, assessing previous infection rates, confirmation of infection, use of convalescent (passive antibody therapy) plasma and assessment of vaccination programmes. Fig. 1 . Open in a separate window Fig. 1 MosaiQ COVID-19 micro-array.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41577d71ba8cc9d7a03c747435def5bc https://pubmed.ncbi.nlm.nih.gov/35262009 Zobrazit plný text záznamu